Variant report
Variant | esv3344188 |
---|---|
Chromosome Location | chr5:45495799-45525161 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560938510 | chr5:45495879-45495880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs199863074 | chr5:45495887-45495888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530351837 | chr5:45495909-45495910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540820191 | chr5:45495931-45495932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560812849 | chr5:45495996-45495997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10473388 | chr5:45496017-45496018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532697576 | chr5:45496066-45496067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536590522 | chr5:45496116-45496117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552792320 | chr5:45496160-45496161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569171263 | chr5:45496171-45496172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531701380 | chr5:45496183-45496184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548301651 | chr5:45496187-45496188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568201454 | chr5:45496208-45496209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557815199 | chr5:45496212-45496213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552748643 | chr5:45496213-45496214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566617715 | chr5:45496250-45496251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538566713 | chr5:45496348-45496349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200896377 | chr5:45496422-45496423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558782148 | chr5:45496444-45496445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575154469 | chr5:45496447-45496448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572997644 | chr5:45496479-45496480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554743771 | chr5:45496481-45496482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534009609 | chr5:45496488-45496489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183116211 | chr5:45496494-45496495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560676513 | chr5:45496548-45496549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532703047 | chr5:45496553-45496554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140626355 | chr5:45496563-45496564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563173486 | chr5:45496575-45496576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs186886711 | chr5:45496576-45496577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548170191 | chr5:45496588-45496589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192086460 | chr5:45496605-45496606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184017022 | chr5:45496606-45496607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547445915 | chr5:45496642-45496643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs566564707 | chr5:45496643-45496644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538800296 | chr5:45496675-45496676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552218153 | chr5:45496688-45496689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569121846 | chr5:45496734-45496735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375456771 | chr5:45496742-45496743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554608021 | chr5:45496743-45496744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530227428 | chr5:45496747-45496748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574444731 | chr5:45496756-45496757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533886090 | chr5:45496843-45496844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553872670 | chr5:45496850-45496851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577392237 | chr5:45496857-45496858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187774233 | chr5:45496899-45496900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563080689 | chr5:45496901-45496902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576672791 | chr5:45496918-45496919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542073894 | chr5:45496935-45496936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200224515 | chr5:45496947-45496948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368409678 | chr5:45496948-45496949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:45492000-45500200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr5:45505800-45509600 | Enhancers | Fetal Brain Female | brain |
3 | chr5:45506400-45506600 | Enhancers | Fetal Brain Male | brain |
4 | chr5:45506600-45507600 | Weak transcription | Fetal Brain Male | brain |
5 | chr5:45507200-45507600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr5:45507200-45507800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr5:45507200-45508400 | Enhancers | Brain Germinal Matrix | brain |
8 | chr5:45507400-45507600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr5:45507400-45507600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
10 | chr5:45507600-45510000 | Enhancers | Fetal Brain Male | brain |
11 | chr5:45509600-45510800 | Weak transcription | Fetal Brain Female | brain |
12 | chr5:45510800-45511000 | Enhancers | Fetal Brain Female | brain |
13 | chr5:45515400-45516200 | Enhancers | Fetal Heart | heart |
14 | chr5:45518200-45518600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr5:45518600-45524000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr5:45520800-45521200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr5:45520800-45521200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr5:45521000-45521400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr5:45521400-45521800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
20 | chr5:45521400-45521800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
21 | chr5:45524000-45524200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr5:45524200-45526400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |